CAS No |
Product Name |
Molecular Formula |
836-44-2
|
4'-Amino-4-Hydroxystilbene
|
C14H13NO
|
836-58-8
|
1-[2-(4-Bromo-Phenoxy)-Ethyl]-Piperidine
|
C13H18BrNO
|
836-59-9
|
4-[2-(4-Bromophenoxy)Ethyl]Morpholine
|
C12H16BrNO2
|
836-79-3
|
1,1,1,3,3,3-Hexafluoro-2-(4-Hydroxyphenyl)Propan-2-Ol
|
C9H6F6O2
|
837-08-1
|
2-[1-(4-Hydroxyphenyl)-1-Methylethyl]Phenol
|
C15H16O2
|
837-12-7
|
1-[(4-Bromophenyl)sulfonyl]-4-methylpiperazine
|
C11H15BrN2O2S
|
837-18-3
|
N-Benzylbenzenesulfonamide
|
C13H13NO2S
|
837-45-6
|
9-Phenanthrenecarboxylic acid
|
C15H10O2
|
837-52-5
|
7-Chloro-4-piperazinoquinoline
|
C13H14ClN3
|
837-83-2
|
Glycyl-L-prolyl-L-alanine;Glycylprolylalanine; NSC 97941
|
C10H17N3O4
|
837-95-6
|
2-Nitro-4-(trifluoromethyl)benzenesulfonyl chloride;2-Nitro-4-(trifluoromethyl)benzenesulphonyl chloride
|
C7H3ClF3NO4S
|
838-07-3
|
5-Methyl-2'-deoxycytidine;2'-Deoxy-5-methylcytidine
|
C10H15N3O4
|
838-22-2
|
4-Methoxy-4'-Methylbenzhydrol
|
C15H16O2
|
838-40-4
|
2,5-Diphenyl-1H-Pyrrole
|
C16H13N
|
838-41-5
|
2,4-Diphenyloxazole
|
C15H11NO
|
838-57-3
|
Ethyl 4-Nitrobenzoylacetate
|
C11H11NO5
|
838-59-5
|
Di(alpha-Phenylethyl) Sulfide
|
C16H18S
|
838-85-7
|
Diphenyl phosphate;Diphenyl hydrogen phosphate
|
C12H11O4P
|
838-88-0
|
4,4'-Diamino-3,3'-dimethyldiphenylmethane;4,4'-Methylenebis(2-methylaniline)
|
C15H18N2
|
838-96-0
|
4-Benzyloxyphenylacetonitrile;4-Benzyloxybenzyl cyanide
|
C15H13NO
|
839-78-1
|
4-Fluorosulfonyl-1-Hydroxy-2-Naphthoic Acid
|
C11H7FO5S
|
839-90-7
|
1,3,5-Tris(2-hydroxyethyl)cyanuric acid;1,3,5-Tris(2-hydroxyethyl)-1,3,5-triazinane-2,4,6-trione
|
C9H15N3O6
|
839-93-0
|
1-(2,4-Dinitrophenyl)Piperidine
|
C11H13N3O4
|
840-65-3
|
2,6-Naphthalic acid dimethyl ester;Dimethyl 2,6-naphthalate; Dimethyl 2,6-naphthalenedicarboxylate; NSC 59387
|
C14H12O4
|
840-97-1
|
Ethyl N-acetyl-L-tyrosinate
|
C13H17NO4
|
841-06-5
|
Metoprotryne;2-Methylthio-4-isopropylamino-6-(gamma-methoxypropylamino)-s-triazine; G 36393; Gesaran; Gesaran 25; Methoproptryne; Methoprotryn; Methoprotryne; Methotryne; Metoprotryn
|
C11H21N5OS
|
841-32-7
|
2,2-Diphenylpentanoic acid
|
C17H18O2
|
841-67-8
|
(-)-Thalidomide
|
C13H10N2O4
|
841-77-0
|
1-(Diphenylmethyl)piperazine;Benzhydrylpiperazine
|
C17H20N2
|
842-01-3
|
7,8-Dihydroxy-4-phenylcoumarin;4-Phenyldaphnetin; Coumarin 8; LDN 0063260
|
C15H10O4
|
842-07-9
|
Sudan I;1-Phenylazo-2-naphthol; C.I. 12055; Solvent Yellow 14
|
C16H12N2O
|
842-15-9
|
Monopotassium 7-aminonaphthalene-1,3-disulfonate
|
C10H8NO6S2.K
|
842-17-1
|
7-Amino-1,3-Naphthalenedisulfonic Acid Disodium Salt
|
C10H7NNa2O6S2
|
842-18-2
|
Dipotassium 7-hydroxynaphthalene-1,3-disulphonate;2-Naphthol-6,8-disulfonic acid dipotassium salt; 7-Hydroxy-1,3-naphthalenedisulfonic acid dipotassium salt; G salt
|
C10H6K2O7S2
|
843-33-4
|
4-(4-Nitrophenylazo)Catechol
|
C12H9N3O4
|
843-55-0
|
4,4'-Cyclohexylidenebisphenol;Bisphenol Z
|
C18H20O2
|
843-59-4
|
Diethyl 2,5-dioxobicyclo(2.2.2)octane-1,4-dicarboxylate
|
C14H18O6
|
844-25-7
|
1-Cyano-2-Benzoyl-1,2-Dihydroisoquinoline
|
C17H12N2O
|
844-51-9
|
2,5-Diphenylquinone;2,5-Diphenyl-1,4-benzoquinone
|
C18H12O2
|
845-05-6
|
4'-Methoxy-3-(Trifluoromethyl)Benzophenone
|
C15H11F3O2
|
845-10-3
|
Methyl Red sodium salt;C.I. 13020; 2-(4-(Dimethylamino)phenylazo)benzoic acid sodium salt
|
C15H14N3NaO2
|
845-46-5
|
4-(4-Dimethylaminophenylazo)Benzoic Acid Sodium Salt
|
C15H14N3NaO2
|
846-46-8
|
5a-Androstanedione;5a-Androstanedione; 5a-Androstan-3,17-dione
|
C19H28O2
|
846-48-0
|
Boldenone;1-Dehydrotestosterone; 17b-Hydroxyandrosta-1,4-dien-3-one
|
C19H26O2
|
846-49-1
|
Lorazepam;7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
|
C15H10Cl2N2O2
|
846-50-4
|
Temazepam
|
C16H13ClN2O2
|
846-63-9
|
2-(1-Naphthyl)-5-phenyloxazole;2-alpha-Naphthyl-5-phenyloxazole; ANPO; NSC 24857
|
C19H13NO
|
846-70-8
|
Naphthol Yellow S;8-Hydroxy-5,7-dinitronaphthalene-2-sulfonic acid sodium salt
|
C10H4N2Na2O8S
|
847-39-2
|
2,5-Bis(4-Methoxyphenyl)-1,3,4-Oxadiazole
|
C16H14N2O3
|
847-83-6
|
4-Methoxytrityl Alcohol
|
C20H18O2
|